Literature DB >> 2478445

The gene encoding human low-molecular weight insulin-like growth-factor binding protein (IGF-BP25): regional localization to 7p12-p13 and description of a DNA polymorphism.

T Alitalo1, K Kontula, R Koistinen, K Aalto-Setälä, M Julkunen, O A Jänne, M Seppälä, A de la Chapelle.   

Abstract

The low-molecular weight insulin-like growth-factor binding protein (IGF-BP25) is synthesized by human liver, secretory endometrium and decidua, and is also present in human serum. It binds insulin-like growth factors IGF-I and IGF-II with high affinity, and is proposed to act as a paracrine regulator of cell growth. In situ hybridization studies with a cDNA encompassing the entire protein coding region of IGF-BP25 localized the gene to bands p12-p13 on chromosome 7. Southern blot analysis with the enzyme BglII revealed a common restriction fragment length polymorphism: the presence of the polymorphic BglII site results in the formation of two fragments 4.6 kb and 1.6 kb in size whereas its absence produces a single 6.2 kb fragment. The frequencies of the two alleles were 0.73 and 0.27, respectively. IGF-BP25 constitutes a useful genetic marker for the proximal short arm of chromosome 7.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478445     DOI: 10.1007/bf00291377

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  26 in total

1.  Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulinlike growth factor I.

Authors:  D R Clemmons; R G Elgin; V K Han; S J Casella; A J D'Ercole; J J Van Wyk
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

2.  Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma.

Authors:  R C Baxter; C T Cowell
Journal:  J Clin Endocrinol Metab       Date:  1987-09       Impact factor: 5.958

3.  Cloning, characterization, and expression of a human insulin-like growth factor binding protein.

Authors:  M T Brewer; G L Stetler; C H Squires; R C Thompson; W H Busby; D R Clemmons
Journal:  Biochem Biophys Res Commun       Date:  1988-05-16       Impact factor: 3.575

4.  Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action.

Authors:  E M Rutanen; F Pekonen; T Mäkinen
Journal:  J Clin Endocrinol Metab       Date:  1988-01       Impact factor: 5.958

5.  Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein.

Authors:  W I Wood; G Cachianes; W J Henzel; G A Winslow; S A Spencer; R Hellmiss; J L Martin; R C Baxter
Journal:  Mol Endocrinol       Date:  1988-12

6.  An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I.

Authors:  R G Elgin; W H Busby; D R Clemmons
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  Report of the committee on the genetic constitution of chromosomes 7 and 8.

Authors:  L C Tsui; M Farrall; H Donis-Keller
Journal:  Cytogenet Cell Genet       Date:  1988

8.  Partial purification and characterization of a binding protein for insulin-like activity (ILAs) in human amniotic fluid: a possible inhibitor of insulin-like activity.

Authors:  S L Drop; G Valiquette; H J Guyda; M T Corvol; B I Posner
Journal:  Acta Endocrinol (Copenh)       Date:  1979-03

9.  Polymorphic DNA region adjacent to the 5' end of the human insulin gene.

Authors:  G I Bell; J H Karam; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

10.  Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein.

Authors:  D J Knauer; G L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  4 in total

Review 1.  The insulin-like growth factor family of ligands, receptors, and binding proteins.

Authors:  R F Krywicki; D Yee
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3.

Authors:  M Harrela; H Koistinen; J Kaprio; M Lehtovirta; J Tuomilehto; J Eriksson; L Toivanen; M Koskenvuo; P Leinonen; R Koistinen; M Seppälä
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

3.  Localization of the human insulin-like growth-factor-binding protein 4 gene to chromosomal region 17q12-21.1.

Authors:  S Bajalica; S V Allander; E Ehrenborg; K Brøndum-Nielsen; H Luthman; C Larsson
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

4.  Partial isodisomy for maternal chromosome 7 and short stature in an individual with a mutation at the COL1A2 locus.

Authors:  L D Spotila; L Sereda; D J Prockop
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.